Patrícia Ferrareze

Mrs. Patrícia Ferrareze


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2016 in Biocatalysis and Agricultural Biotechnology
Verified
Journal Article
Closed access
PFPatrícia Ferrareze
Patrícia Ferrareze
ACAna Paula Folmer Correa
Ana Paula Folmer Correa
ABAdriano Brandelli
Adriano Brandelli

27 January 2021 in bioRxiv
Verified
Preprint
Open access
PDF file
PFPatrícia Ferrareze
Patrícia Ferrareze
VFVinícius Bonetti Franceschi
Vinícius Bonetti Franceschi
Amanda Menezes MayerAmanda Menezes Mayer
Amanda Menezes Mayer
GCGabriel Caldana
Gabriel Caldana
RZRicardo Ariel Zimerman
Ricardo Ariel Zimerman
CTClaudia Elizabeth Thompson
Claudia Elizabeth Thompson
The COVID-19 pandemic caused by SARS-CoV-2 has affected millions of people since its beginning in 2019. The propagation of new lineages and the discovery of key mechanisms adopted by the virus to overlap the immune system are central topics for the entire public health policies, research and disease management. Since the second semester of 2020, the mutation E484K has been progressively found in the Brazilian territory, composing different lineages over time. It brought multiple concerns related to the risk of reinfection and the effectiveness of new preventive and treatment strategies due to the possibility of escaping from neutralizing antibodies. To better characterize the current scenario we performed genomic and phylogenetic analyses of the E484K mutated genomes sequenced from Brazilian samples in 2020. From October, 2020, more than 40% of the sequenced genomes present the E484K mutation, which was identified in three different lineages (P1, P2 and B.1.1.33) in four Brazilian regions. We also evaluated the presence of E484K associated mutations and identified selective pressures acting on the spike protein, leading us to some insights about adaptive and purifying selection driving the virus evolution.

25 April 2018 in mSphere
Verified
Journal Article
Open access
PDF file
JRJulia Catarina Vieira Reuwsaat
Julia Catarina Vieira Reuwsaat
HMHeryk Motta
Heryk Motta
AGAne Wichine Acosta Garcia
Ane Wichine Acosta Garcia
CVCarolina Bettker Vasconcelos
Carolina Bettker Vasconcelos
BMBárbara Machado Marques
Bárbara Machado Marques
LKLívia Kmetzsch
Lívia Kmetzsch
The yeast-like pathogen Cryptococcus gattii is an etiological agent of cryptococcosis. The major cryptococcal virulence factor is the polysaccharide capsule, which is composed of glucuronoxylomannan (GXM), galactoxylomannan (GalXM), and mannoproteins (MPs). The GXM and GalXM polysaccharides have been extensively characterized; however, there is little information about the role of mannoproteins in capsule assembly and their participation in yeast pathogenicity. The present study characterized the function of a predicted mannoprotein from C. gattii, designated Krp1. Loss-of-function and gain-of-function mutants were generated, and phenotypes associated with the capsular architecture were evaluated. The null mutant cells were more sensitive to a cell wall stressor that disrupts beta-glucan synthesis. Also, these cells displayed increased GXM release to the culture supernatant than the wild-type strain did. The loss of Krp1 influenced cell-associated cryptococcal polysaccharide thickness and phagocytosis by J774.A1 macrophages in the early hours of interaction, but no difference in virulence in a murine model of cryptococcosis was observed. In addition, recombinant Krp1 was antigenic and differentially recognized by serum from an individual with cryptococcosis, but not with serum from an individual with candidiasis. Taken together, these results indicate that C. gattii Krp1 is important for the cell wall structure, thereby influencing capsule assembly, but is not essential for virulence in vivo. IMPORTANCECryptococcus gattii has the ability to escape from the host’s immune system through poorly understood mechanisms and can lead to the death of healthy individuals. The role of mannoproteins in C. gattii pathogenicity is not completely understood. The present work characterized a protein, Kpr1, that is essential for the maintenance of C. gattii main virulence factor, the polysaccharide capsule. Our data contribute to the understanding of the role of Kpr1 in capsule structuring, mainly by modulating the distribution of glucans in C. gattii cell wall.

23 August 2017 in Microorganisms
Verified
Journal Article
Open access
PDF file
PFPatrícia Ferrareze
Patrícia Ferrareze
RSRodrigo Silva Araujo Streit
Rodrigo Silva Araujo Streit
PSPatricia Ribeiro dos Santos
Patricia Ribeiro dos Santos
FSFrancine Melise dos Santos
Francine Melise dos Santos
RARita De Almeida
Rita De Almeida
CSCharley Christian Staats
Charley Christian Staats
Cryptococcus gattii is a human and animal pathogen that infects healthy hosts and caused the Pacific Northwest outbreak of cryptococcosis. The inhalation of infectious propagules can lead to internalization of cryptococcal cells by alveolar macrophages, a niche in which C. gattii cells can survive and proliferate. Although the nutrient composition of macrophages is relatively unknown, the high induction of amino acid transporter genes inside the phagosome indicates a preference for amino acid uptake instead of synthesis. However, the presence of countable errors in the R265 genome annotation indicates significant inhibition of transcriptomic analysis in this hypervirulent strain. Thus, we analyzed RNA-Seq data from in vivo and in vitro cultures of C. gattii R265 to perform the reannotation of the genome. In addition, based on in vivo transcriptomic data, we identified highly expressed genes and pathways of amino acid metabolism that would enable C. gattii to survive and proliferate in vivo. Importantly, we identified high expression in three APC amino acid transporters as well as the GABA permease. The use of amino acids as carbon and nitrogen sources, releasing ammonium and generating carbohydrate metabolism intermediaries, also explains the high expression of components of several degradative pathways, since glucose starvation is an important host defense mechanism.

1 October 2021 in Virus Research
Verified
Journal Article
Closed access
VFVinícius Bonetti Franceschi
Vinícius Bonetti Franceschi
PFPatrícia Ferrareze
Patrícia Ferrareze
RZRicardo Ariel Zimerman
Ricardo Ariel Zimerman
GCGabriela Bettella Cybis
Gabriela Bettella Cybis
CTClaudia Elizabeth Thompson
Claudia Elizabeth Thompson

5 August 2021 in Pathogens
Verified
Journal Article
Open access
PDF file
VFVinícius Bonetti Franceschi
Vinícius Bonetti Franceschi
GCGabriel Caldana
Gabriel Caldana
CPChristiano Perin
Christiano Perin
AHAlexandre Horn
Alexandre Horn
CPCamila Peter
Camila Peter
CTClaudia Elizabeth Thompson
Claudia Elizabeth Thompson
Almost a year after the COVID-19 pandemic had begun, new lineages (B.1.1.7, B.1.351, P.1, and B.1.617.2) associated with enhanced transmissibility, immunity evasion, and mortality were identified in the United Kingdom, South Africa, and Brazil. The previous most prevalent lineages in the state of Rio Grande do Sul (RS, Southern Brazil), B.1.1.28 and B.1.1.33, were rapidly replaced by P.1 and P.2, two B.1.1.28-derived lineages harboring the E484K mutation. To perform a genomic characterization from the metropolitan region of Porto Alegre, we sequenced viral samples to: (i) identify the prevalence of SARS-CoV-2 lineages in the region, the state, and bordering countries/regions; (ii) characterize the mutation spectra; (iii) hypothesize viral dispersal routes by using phylogenetic and phylogeographic approaches. We found that 96.4% of the samples belonged to the P.1 lineage and approximately 20% of them were assigned as the novel P.1.2, a P.1-derived sublineage harboring signature substitutions recently described in other Brazilian states and foreign countries. Moreover, sequences from this study were allocated in distinct branches of the P.1 phylogeny, suggesting multiple introductions in RS and placing this state as a potential diffusion core of P.1-derived clades and the emergence of P.1.2. It is uncertain whether the emergence of P.1.2 and other P.1 clades is related to clinical or epidemiological consequences. However, the clear signs of molecular diversity from the recently introduced P.1 warrant further genomic surveillance.